Actively Recruiting
Metastatic Breast Cancer in Austria Registry: A Multicenter Observational Study Documenting Tumor Characteristics and Treatment Outcomes
Led by Arbeitsgemeinschaft medikamentoese Tumortherapie · Updated on 2025-04-10
5000
Participants Needed
16
Research Sites
N/A
Total Duration
On this page
Sponsors
A
Arbeitsgemeinschaft medikamentoese Tumortherapie
Lead Sponsor
H
Hoffmann-La Roche
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying metastatic breast cancer, the most common cancer among women worldwide, with a focus on patients in Austria. This study is the first Austrian-wide registry to systematically collect and document data on metastatic breast cancer cases. The aim is to understand epidemiological trends and treatment patterns, including tumor characteristics and patient outcomes. The study collects both retrospective and prospective data from multiple centers across Austria. It records detailed information on tumor subtypes, initial disease progression, treatment sequences, and patient medical histories. This registry also includes data on male breast cancer patients to assess gender differences in treatment and outcomes. Participants provide anonymized medical information, including tumor characteristics, treatment details, and survival data. Researchers will analyze patterns of metastasis, treatment responses, and survival rates at 1, 2, and 5 years after metastasis diagnosis. The registry aims to offer insights into treatment quality and outcomes over a 10-year period.
CONDITIONS
Brief Title
Metastatic Breast Cancer in Austria
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histological evidence of breast cancer
- Histological and/or radiological evidence of metastases
- Metastasis within 10 years of registry initiation
- Signed informed consent (or entry without consent if patient deceased at entry)
You will not qualify if you...
- No specific exclusion criteria due to the non-interventional design of the registry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants who undergo routine care are observed to document tumor characteristics, treatment outcomes, and survival data over time.
Visits as per routine clinical care
Trial Site Locations
Total: 16 locations
1
Landeskrankenhaus Salzburg Universitätsklinikum der Paracelsus Medizinischen Privatuniversität; Universitätsklinik für Innere Medizin III Salzburg
Salzburg, State of Salzburg, Austria, 5020
Actively Recruiting
2
AKH Wien; Universitätsklinik für Frauenheilkunde: Klin. Abt. f. Allg. Gynäkologie und gynäkologische Onkologie
Vienna, State of Vienna, Austria, 1090
Actively Recruiting
3
Steiermärkische Krankenanstalten- gesellschaft m. b. H. LKH-Univ. Klinikum Graz; Universitätsklinik für Innere Medizin; Klinische Abteilung für Onkologie
Graz, Styria, Austria, 8036
Actively Recruiting
4
Landeskrankenhaus - Universitätskliniken Innsbruck; Universitätsklinik für Frauenheilkunde Innsbruck
Innsbruck, Tyrol, Austria, 6020
Actively Recruiting
5
BKH Kufstein; Innere Medizin: Interne II und onk. Tagesklinik
Kufstein, Tyrol, Austria, 6330
Actively Recruiting
6
Kepler Universitätsklinikum; Univ.-Klinik für Hämatologie und Internistische Onkologie
Linz, Upper Austria, Austria, 4020
Actively Recruiting
7
Ordensklinikum Linz GmbH - Barmherzige Schwestern; Interne I: Medizinische Onkologie und Hämatologie
Linz, Upper Austria, Austria, 4020
Actively Recruiting
8
Pyhrn-Eisenwurzen Klinikum Steyr; Innere Medizin II: Onkologie, Gastroenterologie, Angiologie
Steyr, Upper Austria, Austria, 4400
Actively Recruiting
9
Klinikum Wels-Grieskirchen GmbH; Abteilung für Innere Medizin IV
Wels, Upper Austria, Austria, 4600
Actively Recruiting
10
LKH Feldkirch; Innere Medizin II/ Interne E (Hämatologie und Onkologie)
Feldkirch, Vorarlberg, Austria, 6800
Actively Recruiting
11
Krankenhaus St. Josef Braunau; Inneren Medizin 2
Braunau am Inn, Austria, 5280
Actively Recruiting
12
Krankenhaus der Stadt Dornbirn; Brustgesundheitszentrum Dornbirn
Dornbirn, Austria, 6850
Actively Recruiting
13
Steiermärkische Krankenanstalten- gesellschaft m.b.H. LKH Hochsteiermark; Department für Hämato-Onkologie
Leoben, Austria, 8700
Actively Recruiting
14
Universitätsklinikum St. Pölten; Abteilung für Innere Medizin 1
Sankt Pölten, Austria, 3100
Actively Recruiting
15
UK AKH Wien: Universitätsklinik für Innere Medizin I: Klinische Abteilung für Onkologie
Vienna, Austria, 1090
Actively Recruiting
16
Klinik Ottakring; 1. Med. Abteilung, Zentrum f. Onkologie, Hämatologie und Palliativmedizin
Vienna, Austria, 1160
Actively Recruiting
Research Team
D
Daniela Wolkersdorfer
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here